Senti Biosciences is trading 5.8% up at $0.39 as part of a broader rebound in biotech and a shift toward risk-on sentiment.
- The move extends an 8.7% gain from August 03, 2026, as the stock continues to build on recent momentum.
- There are no new company-specific headlines, suggesting traders are primarily responding to sector strength and supportive macro data rather than fresh fundamental news.